Prognostic risk factors for inflammatory process exacerbation in the urinary tract in patients with urolithiasis after laser lithotripsy

Authors

DOI:

https://doi.org/10.14739/2310-1210.2026.3.356134

Keywords:

urolithiasis, nephrolithiasis, laser lithotripsy, treatment, surgical treatment, inflammation, comorbidity, prognosis, risk factors, urothelium

Abstract

Aim. To identify informative clinical and prognostic risk factors for urinary tract inflammatory exacerbation in patients with urolithiasis (UL) after laser lithotripsy.

Materials and methods. The study included 74 patients with UL who underwent laser lithotripsy using the holmium laser MultiPulse HoPlus (Germany) in fragmentation mode with a pulse energy of 1.2 J, a frequency of 20 Hz. Patients were divided into groups according to the presence of laboratory signs of urinary tract inflammation on the second postoperative day. Urinalysis for all patients was performed using an automated urine analyser, Laura Xl Erba (Germany). The obtained data were statistically processed with Statistica 13 for Windows (StatSoft Inc., No. JPZ804I382130ARCN10-J).

Results. On the second day after laser lithotripsy, 48.6 % of patients with UL presented with laboratory signs of urinary tract inflammatory exacerbation, characterized by leukocyturia (100 %), elevated epithelial cell count (72.2 %), erythrocyturia (100 %), bacteriuria (88.9 %), and crystalluria (83.3 %). The signs of urinary tract inflammatory exacerbation were correlated with acute inflammatory indicators. Inflammatory changes on the second postoperative day were significantly more frequent in patients with comorbid diabetes mellitus (р = 0.03), chronic pyelonephritis in remission at the time of lithotripsy (р = 0.04) and their combination (р = 0.04). The duration of laser lithotripsy of ≥60 minutes was associated with a higher frequency of urinary tract inflammation (р = 0.01 in patients with UL on the second day after lithotripsy. The most informative independent prognostic risk factors for urinary tract inflammatory exacerbation in patients with UL on the second postoperative day were comorbid chronic pyelonephritis (p = 0.040) and lithotripsy duration ≥60 minutes (p = 0.016).

Conclusions. Comorbid chronic pyelonephritis and lithotripsy duration ≥60 minutes are significant prognostic risk factors for urinary tract inflammatory exacerbation in patients with UL on the second day after laser lithotripsy.

Author Biographies

V. O. Morhuntsov, Zaporizhzhia State Medical and Pharmaceutical University

MD, PhD student at the Department of Urology

O. O. Lyulko, Zaporizhzhia State Medical and Pharmaceutical University

MD, PhD, DSc, Professor of the Department of Urology

O. V. Riabokon, Zaporizhzhia State Medical and Pharmaceutical University

MD, PhD, DSc, Professor, Head of the Department of Infectious Diseases

References

  1. Stamatelou K, Goldfarb DS. Epidemiology of kidney stones. Health (Basel). 2023;11(3):424. doi: https://doi.org/10.3390/healthcare11030424
    | |
  2. Emami E, Heidari-Soureshjani S, Oroojeni Mohammadjavad A, Sherwin CM. Obesity and the Risk of Developing Kidney Stones: A Systematic Review and Meta-analysis. Iran J Kidney Dis. 2023;17(2):63-72. 37060339
    | |
  3. Lu Z, Chen Y, Tang Z, Zhang J, Li Z, Tang F, et al. Basal metabolic rate and the risk of urolithiasis: a two-sample Mendelian randomization study. World J Urol. 2024;42(1):235. doi: https://doi.org/10.1007/s00345-024-04946-x
    | |
  4. GBD 2021 Urolithiasis Collaborators. The global, regional, and national burden of urolithiasis in 204 countries and territories, 2000-2021: a systematic analysis for the Global Burden of Disease Study 2021. EClinicalMedicine. 2024;78:102924. doi: https://doi.org/10.1016/j.eclinm.2024.102924
    | |
  5. Ye S, Wang W, Yu Z, Luo J. Risk factors for systemic inflammatory response syndrome after endoscopic lithotripsy for upper urinary calculi. BMC Urol. 2023;23(1):59. doi: https://doi.org/10.1186/s12894-023-01230-9
    | |
  6. Pagonis K, Katsakiori P, Peteinaris A, Tatanis V, Tsaturyan A, Faria Costa G, et al. High-power Holmium:Yag lithotripsy in bladder urolithiasis: Is it safe and effective? A combined clinical and experimental study. Arab J Urol. 2024;22(3):145-51. doi: https://doi.org/10.1080/20905998.2024.2304516
    | |
  7. Sharma S, Sabale V, Satav V, Mulay A. To Evaluate the Impact of Ho:YAG Laser Lithotripsy for Ureteroscopic Removal of Proximal and Distal Ureter Calculi. Cureus. 2023;15(10):e47498. doi: https://doi.org/10.7759/cureus.47498
    |
  8. De Coninck V, Keller EX, Somani B, Giusti G, Proietti S, Rodriguez-Socarras M, et al. Complications of ureteroscopy: a complete overview. World J Urol. 2020;38(9):2147-66. doi: https://doi.org/10.1007/s00345-019-03012-1
    | |
  9. Yuan Q, Guo J, He L, Chen Q, Zou X, Yang S, et al. Retrospective analysis of the risk factors and drug resistance of pathogenic bacteria in systemic inflammatory response syndrome after ureteroscopic holmium laser lithotripsy for impacted ureteral calculi. Int J Gen Med. 2022;15:3923-31. doi: https://doi.org/10.2147/IJGM.S356540
    | |
  10. Hatt JK, Rather PN. Role of bacterial biofilms in urinary tract infections. Curr Top Microbiol Immunol. 2008;322:163-92. doi: https://doi.org/10.1007/978-3-540-75418-3_8
    | |
  11. Tokas T, Herrmann T, Skolarikos A, Nagele U; Training and Research in Urological Surgery and Technology (T.R.U.S.T.)-Group. Pressure matters: intrarenal pressures during normal and pathological conditions, and impact of increased values to renal physiology. World J Urol. 2019;37(1):125-31. doi: https://doi.org/10.1007/s00345-018-2378-4
    | |
  12. Ortner G, Rice P, Nagele U, Herrmann T, Somani BK, Tokas T. Tissue thermal effect during lithotripsy and tissue ablation in endourology: a systematic review of experimental studies comparing Holmium and Thulium lasers. World J Urol. 2023;41(1):1-12. doi: https://doi.org/10.1007/s00345-022-04242-6
    | |
  13. Senocak C, Ozcan C, Sahin T, Yilmaz G, Ozyuvali E, Sarikaya S, et al. Risk Factors of Infectious Complications after Flexible Uretero-renoscopy with Laser Lithotripsy. Urol J. 2018;15(4):158-63. doi: https://doi.org/10.22037/uj.v0i0.3967
    | |
  14. Pischetola A, Hughes T, Geraghty R, Boulmani M, Somani BK. Incidence of urinary infections and urosepsis after ureteroscopy for stone disease: a systematic review of literature. Ther Adv Urol. 2026;18:17562872251412050. doi: https://doi.org/10.1177/17562872251412050
    | |
  15. Nevo A, Mano R, Baniel J, Lifshitz DA. Ureteric stent dwelling time: a risk factor for post-ureteroscopy sepsis. BJU Int. 2017;120(1):117-22. doi: https://doi.org/10.1111/bju.13796
    | |
  16. Yang Y, Tang Y, Bai Y, Wang X, Feng D, Han P. Preoperative double-J stent placement can improve the stone-free rate for patients undergoing ureteroscopic lithotripsy: a systematic review and meta-analysis. Urolithiasis. 2018;46(5):493-9. doi: https://doi.org/10.1007/s00240-017-1012-z
    | |
  17. Tobe T, Inoue T, Yamamichi F, Tominaga K, Fujita M, Fujisawa M, Miyake H. Predictive factors for prolonged operative time in ureteroscopic lithotripsy for ureteral stones A retrospective cohort study. Can Urol Assoc J. 2024;18(9):E261-8. doi: https://doi.org/10.5489/cuaj.8713
    | |
  18. Jayanth, Paul R. F, Gopi R, Singh R. Predictors of febrile urinary tract infection after ureterorenoscopy for urinary stones. Int Surg J. 2023;10(12):1925-9. doi: https://doi.org/10.18203/2349-2902.isj20233673
  19. Homsy Y, Arnold P, Zhang W. Phase IIb/III dose ranging study of tamsulosin as treatment for children with neuropathic bladder. J Urol [Internet]. 2011;186(5):2033–9. Available from: http://dx.doi.org/10.1016/j.juro.2011.07.021
    | |
  20. Li X, Liu C, Mao Z, Xiao M, Wang L, Qi S, Zhou F. Predictive values of neutrophil-to-lymphocyte ratio on disease severity and mortality in COVID-19 patients: a systematic review and meta-analysis. Crit Care. 2020;24(1):647. doi: https://doi.org/10.1186/s13054-020-03374-8
    | |
  21. Ma YC, Jian ZY, Yuan C, Li H, Wang KJ. Risk Factors of Infectious Complications after Ureteroscopy: A Systematic Review and Meta-Analysis Based on Adjusted Effect Estimate. Surg Infect (Larchmt). 2020;21(10):811-22. doi: https://doi.org/10.1089/sur.2020.013
    | |
  22. Küçük E, Güler H, Ordulu R, Aydın M, Öztürk U, Kırdağ MK, et al. Impact of diabetes mellitus on stone access and surgical outcomes in patients undergoing ureteroscopic lithotripsy: a retrospective cohort study. BMC Urol. 2026;26(1):79. doi: https://doi.org/10.1186/s12894-026-02090-9
    | |
  23. Çakıcı MÇ, Kazan Ö, Çiçek M, İplikçi A, Yıldırım A, Atış G. Predictive risk factors of urinary tract infection following flexible ureteroscopic lithotripsy. Arch Esp Urol. 2021;74(5):503-10. English. PMID: 34080570.
    | |
  24. Bhojani N, Miller LE, Bhattacharyya S, Cutone B, Chew BH. Risk factors for urosepsis after ureteroscopy for stone disease: A systematic review with meta-analysis. J Endourol. 2021;35(7):991-1000. doi: https://doi.org/10.1089/end.2020.1133
    | |
  25. Hong A, Leroi M, Alberto M, Bolton D, Jack G. The exponential relationship between raised intrarenal pressure and bacteraemia. BJU Int. 2026;137(Suppl 3):S78-S85. doi: https://doi.org/10.1111/bju.16856
    | |
  26. Chorbińska J, Krajewski W, Karpiński P, Nowak Ł, Tomczak W, Łaszkiewicz J, et al. Comparison of the microbiome of bladder urine, upper urinary tract urine, and kidney stones in patients with urolithiasis. Cent European J Urol. 2025;78(2):206-20. doi: https://doi.org/10.5173/ceju.2025.0020
    | |
  27. Schwaderer AL, Wolfe AJ. The association between bacteria and urinary stones. Ann Transl Med. 2017;5(2):32. doi: https://doi.org/10.21037/atm.2016.11.73
    | |
  28. Itami Y, Miyake M, Owari T, Iwamoto T, Gotoh D, Momose H, et al. Optimal timing of ureteroscopic lithotripsy after the initial drainage treatment and risk factors for postoperative febrile urinary tract infection in patients with obstructive pyelonephritis: a retrospective study. BMC Urol. 2021;21(1):10. doi: https://doi.org/10.1186/s12894-020-00754-8
    | |
  29. Dai L, Xiang J, Liu X, Wen X, Tan L, Zhang J. Risk factors for urosepsis following ureteroscopic lithotripsy: a systematic review and meta-analysis. Front Surg. 2025;12:1603311. doi: https://doi.org/10.3389/fsurg.2025.1603311
    | |
  30. Ordonez M, Hwang EC, Borofsky M, Bakker CJ, Gandhi S, Dahm P. Ureteral stent versus no ureteral stent for ureteroscopy in the management of renal and ureteral calculi. Cochrane Database Syst Rev. 2019;2(2):CD012703. doi: https://doi.org/10.1002/14651858.CD012703.pub2
    | |
  31. Lei P, Simayi A, Wang S, Liu B, Jia H, Zhang P, Liu Y, Du W, Li J. Comparison of the effects of commonly used double-J stents on stone-free rates and ureteral stent-related symptoms after lithotripsy for upper urinary tract stones. Cent European J Urol. 2026;79(1):23-9. doi: https://doi.org/10.5173/ceju.2024.0276
    | |
  32. Sun J, Xu J, OuYang J. Risk factors of infectious complications following ureteroscopy: A systematic review and meta-analysis. Urol Int. 2020;104(1-2):113-24. doi: https://doi.org/10.1159/000504326
    | |

Downloads

Additional Files

Published

2026-06-11

How to Cite

1.
Morhuntsov VO, Lyulko OO, Riabokon OV. Prognostic risk factors for inflammatory process exacerbation in the urinary tract in patients with urolithiasis after laser lithotripsy. Zaporozhye Medical Journal [Internet]. 2026Jun.11 [cited 2026Jun.11];28(3):211-6. Available from: https://zmj.zsmu.edu.ua/article/view/356134

Issue

Vol. 28 No. 3 (2026): Zaporozhye Medical Journal

Section

Original research

License

Copyright (c) 2026 V. O. Morhuntsov, O. O. Lyulko, O. V. Riabokon

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.  Лицензия Creative Commons